HALO AP

Looking Back: Reviewing 2025 at Indica Labs

As we reach the end of 2025, the Indica Labs team extends our sincere thanks to the customers and collaborators who helped make this year one of remarkable innovation, growth, and scientific achievement.

Looking Back: Reviewing 2025 at Indica Labs Read More »

The rapid global adoption of HALO AP® prompted immediate localization of the platform in Chinese, Danish, Dutch, American and British English, Finnish, French, German, Greek, Italian, Norwegian, Japanese, Portuguese, Russian, Spanish, Slovakian, and Swedish. Shown here are all 17 languages represented as each country's flags.

Indica Labs Reports 260% Clinical Revenue Growth and Expansion into New Global Markets

Albuquerque, NM, December 17, 2025 – Indica Labs, the global leader in AI-powered digital pathology, announced today that clinical revenue growth rate for HALO AP® is up 260% since 2023 and recurring revenue for 2025 shows a 200% increase year-over-year, reinforcing its position as a market leader in digital pathology diagnostics.

Indica Labs Reports 260% Clinical Revenue Growth and Expansion into New Global Markets Read More »

Indica Labs, HALO AP Dx, FDA 510(k)-cleared digital pathology platform displayed with the Aperio GT 450 DX Scanner for in vitro diagnostic use.

Indica Labs Receives FDA Clearance for Enterprise Digital Pathology Platform with Industry Leading DICOM-Compatible Aperio Scanner from Leica Biosystems

ALBUQUERQUE, NM, and VISTA, CA, December 3, 2025 – Indica Labs, the global leader of AI-powered digital pathology, and Leica Biosystems, a global leader in anatomic and digital pathology solutions, announced today that the Food and Drug Administration (FDA) has issued a 510(k) clearance for the enterprise digital pathology platform HALO AP Dx in conjunction with Leica Biosystems Aperio GT 450 DX Scanner for in-vitro diagnostic use.

Indica Labs Receives FDA Clearance for Enterprise Digital Pathology Platform with Industry Leading DICOM-Compatible Aperio Scanner from Leica Biosystems Read More »

An Automated Clinical Workflow Integrating an AI-driven PD-L1 22C3 Scoring Algorithm into a Browser-Based Digital Pathology Solution

Discover how Guardant Health has seamlessly integrated Lunit SCOPE PD-L1 with HALO AP® for enhanced PD-L1 analysis.

An Automated Clinical Workflow Integrating an AI-driven PD-L1 22C3 Scoring Algorithm into a Browser-Based Digital Pathology Solution Read More »

Indica Labs’ London HALO® User Group Meeting 2025

9 December 2025 | Indica Labs is pleased to announce our London HALO® User Group Meeting at Hilton London Metropole on 9 December from 12:00 – 16:00 Lunch will be provided to all pre-registered attendees.

Indica Labs’ London HALO® User Group Meeting 2025 Read More »

Multiple South West London Pathology Trusts Select Indica Labs and Leica Biosystems for Advancing Digital Pathology in Clinical Practice

Albuquerque, NM, September 24, 2025 – Indica Labs, the global leader of AI-powered digital pathology, and Leica Biosystems, a global leader in anatomic and digital pathology solutions, announce today that multiple trusts within the South West London Pathology network have chosen the powerful combination of Leica Biosystems Aperio GT 450 DX scanners and Indica Labs’ HALO AP® for digital pathology adoption.

Multiple South West London Pathology Trusts Select Indica Labs and Leica Biosystems for Advancing Digital Pathology in Clinical Practice Read More »

Indica Labs’ Bay Area HALO® User Group Meeting 2025

21 October 2025 | Indica Labs is pleased to announce our Bay Area HALO® User Group Meeting at The Lighthouse Café & Conference Center on 21 October from 10:00am – 3:30pm. Lunch will be provided to all pre-registered attendees at 12:20pm.

Indica Labs’ Bay Area HALO® User Group Meeting 2025 Read More »

Scroll to Top